- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.51 Å
- Oligo State
- homo-trimer
- Ligands
- 6 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 2 residues within 4Å:- Chain A: N.798, S.800
No protein-ligand interaction detected (PLIP)NAG-NAG.3: 2 residues within 4Å:- Chain A: N.1071
- Chain B: Q.892
No protein-ligand interaction detected (PLIP)NAG-NAG.5: 1 residues within 4Å:- Chain A: N.1131
No protein-ligand interaction detected (PLIP)NAG-NAG.7: 2 residues within 4Å:- Chain B: N.798, S.800
No protein-ligand interaction detected (PLIP)NAG-NAG.8: 2 residues within 4Å:- Chain B: N.1071
- Chain C: Q.892
No protein-ligand interaction detected (PLIP)NAG-NAG.10: 1 residues within 4Å:- Chain B: N.1131
No protein-ligand interaction detected (PLIP)NAG-NAG.12: 2 residues within 4Å:- Chain C: N.798, S.800
No protein-ligand interaction detected (PLIP)NAG-NAG.13: 2 residues within 4Å:- Chain A: Q.892
- Chain C: N.1071
No protein-ligand interaction detected (PLIP)NAG-NAG.15: 1 residues within 4Å:- Chain C: N.1131
No protein-ligand interaction detected (PLIP)- 33 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.16: 2 residues within 4Å:- Chain A: Y.25, N.58
Ligand excluded by PLIPNAG.17: 4 residues within 4Å:- Chain A: N.119, T.121, N.122, V.124
Ligand excluded by PLIPNAG.18: 1 residues within 4Å:- Chain A: N.162
Ligand excluded by PLIPNAG.19: 2 residues within 4Å:- Chain A: T.105, N.231
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain A: N.277, E.278, N.279
Ligand excluded by PLIPNAG.21: 2 residues within 4Å:- Chain A: N.328, Q.577
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain A: H.336, N.340
Ligand excluded by PLIPNAG.23: 1 residues within 4Å:- Chain A: N.600
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain A: N.613, T.615
Ligand excluded by PLIPNAG.25: 1 residues within 4Å:- Chain A: N.654
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain A: S.705, N.706
- Chain B: Y.793
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain B: Y.25, N.58
Ligand excluded by PLIPNAG.28: 4 residues within 4Å:- Chain B: N.119, T.121, N.122, V.124
Ligand excluded by PLIPNAG.29: 1 residues within 4Å:- Chain B: N.162
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain B: T.105, N.231
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain B: N.277, E.278, N.279
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain B: N.328, Q.577
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain B: H.336, N.340
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain B: N.600
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain B: N.613, T.615
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain B: N.654
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain B: S.705, N.706
- Chain C: Y.793
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain C: Y.25, N.58
Ligand excluded by PLIPNAG.39: 4 residues within 4Å:- Chain C: N.119, T.121, N.122, V.124
Ligand excluded by PLIPNAG.40: 1 residues within 4Å:- Chain C: N.162
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain C: T.105, N.231
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain C: N.277, E.278, N.279
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain C: N.328, Q.577
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain C: H.336, N.340
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain C: N.600
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain C: N.613, T.615
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain C: N.654
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain A: Y.793
- Chain C: S.705, N.706
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cao, Y. et al., Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75. Cell Host Microbe (2022)
- Release Date
- 2022-10-19
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.51 Å
- Oligo State
- homo-trimer
- Ligands
- 6 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 33 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cao, Y. et al., Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75. Cell Host Microbe (2022)
- Release Date
- 2022-10-19
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C